2017 annual financial data
Viridian Therapeutics 2017 Operating margin
Direct answer
Operating margin was -662.8%.
Operating income was -26,532,000 USD and net income was -26,512,000 USD.
Operating cash flow was -28,167,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,003,000 USD
- Operating income
- -26,532,000 USD
- Net income
- -26,512,000 USD
- Operating cash flow
- -28,167,000 USD